[ Clinical study of the <font color="blue">efficacy_1</font> <font color="blue">of_1</font> <font color="blue">and_1</font> <font color="blue">tolerance_1</font> to nimesulide in suppository formulation in pain - inflammatory pathologies of the ear , nose , and throat ] . 
<br>
<br> The efficacy and tolerability of a new pharmaceutical form of the non - steroid anti - inflammatory drug . Nimesulide have been studied in a double blind study compared with flurbiprofen , in 98 patients aged between 18 and 75 suffering from pain - inflammatory pathologies of ENT nature . Both drugs , administered in a dose of one suppository twice a day for 7 days , showed marked <font color="blue">anti_2</font> <font color="blue">-_2</font> <font color="blue">inflammatory_2</font> <font color="blue">,_2</font> <font color="blue">analgesic_2</font> <font color="blue">and_2</font> <font color="blue">antipyretic_2</font> <font color="blue">activity_2</font> and produced a significant , progressive improvement in the <font color="blue">typical_1</font> <font color="blue">symptoms_1</font> <font color="blue">of_1</font> <font color="blue">the_1</font> <font color="blue">inflammatory_1</font> <font color="blue">state_1</font> up to their <font color="blue">complete_1</font> <font color="blue">remission_1</font> <font color="blue">._1</font> Nimesulide evidenced greater <font color="blue">speed_3</font> <font color="blue">and_3</font> <font color="blue">duration_3</font> <font color="blue">of_2</font> <font color="blue">therapeutic_2</font> <font color="blue">action_2</font> <font color="blue">._2</font> Assessment on the effectiveness and tolerability as expressed separately by the physician and patient were positive in almost all cases of both treatments .